Читать книгу Current Perspectives in Kidney Diseases - Группа авторов - Страница 34

Monitoring Citrate Anticoagulation during CRRT

Оглавление

Measurement of citrate concentration in the blood is not available in the daily routine, so the most commonly accepted clinical markers for citrate accumulation [8] are as follows:

• An increased ratio of total calcium (tCa) to iCa (tCa/iCa),

• Metabolic acidosis with or without an increased anion gap, and

• Elevated demand for calcium substitution.

A calcium ratio (tCa/iCa) of 2.5 is often indicated as the critical threshold for enhanced risk of metabolic complications due to impaired citrate metabolism. Nevertheless, it has been reported that a lower cutoff of 2.1 appears to accurately predict the citrate accumulation (systemic citrate concentration 1 mmol/L) with high sensitivity and specificity (89 and 100%, respectively) [28].

However, the incidence of metabolic disarrangements resulting from citrate accumulation has been found to be rather low since it generally affects less than 3% of all CRRT patients on RCA, and clinical diagnosis of citrate accumulation is found exclusively in severely ill patients with multiorgan failure and severe lactic acidosis [24].

Current Perspectives in Kidney Diseases

Подняться наверх